ArticleOncotarget2019

An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments.

Antonio Marchetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.